Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2) |
| |
| Authors: | PAULINE M. DOWD,M.F.R. MARTIN,E.D. COOKE&dagger ,SALLY A. BOWCOCK&dagger ,R. JONES&Dagger ,P.A. DIEPPE,J.D.T. KIRBY |
| |
| Affiliation: | Department of Rheumatology, Bristol Royal Infirmary, Bristol BS2 8HW, and Department of Dermatology, St Bartholomew's Hospital, London ECrA 7BE;Departrnent of Medical Electronics, St Bartholomew's Hospital, London ECrA 7BE;Department of Haematology, St Bartholomew's Hospital, London ECrA 7BE |
| |
| Abstract: | Twenty five patients with Raynaud's phenomenon due to systemic sclerosis were infused with prostacyclin (PGI2). In 88% of the patients there was objective improvement, monitored by thermography or radiometry. |
| |
| Keywords: | |
|
|
